…s associated with 11.9% greater weight reduction (13 RCTs), and tirzepatide was associated with 16.2% greater weight reduction (6 RCTs).51 …
Liraglutide
This drug is selected. Its supporting articles are shown below.
Articles mentioning Liraglutide
22 articles · page 1 of 2…and upper gastrointestinal cancers were similar between groups. Orlistat was associated with higher risks of kidney stones (5.9% vs 4.5%…
…and upper gastrointestinal cancers were similar between groups. Orlistat was associated with a higher risk of kidney stones (5.9% vs 4.5…
…ufactured GLP-1RA products (active ingredients: liraglutide and semaglutide) in people with type 2 diabetes and/or overweight/obesity. Pote…
…particularly relevant for GLP-1 receptor agonists. For example, semaglutide has demonstrated dose-dependent effects on glycemic control and…
…lin and SGLT2 inhibitors, while DPP-4 inhibitors clustered with metformin ( figure 1). Heatmapping confirmed strong phenotype-specific en…
… among the GLP-1RA group compared with the sulfonylureas group. GLP-1RA=glucagon-like peptide-1 receptor agonistsDiscussionIn this nati…
…78.7%), followed by semaglutide (69.6%), exenatide (49.6%), and liraglutide (39.6%).Cox regression analysis (reference: dulaglutide) showed…
…se in patients with cardiovascular disease and type 2 diabetes. Semaglutide, tirzepatide and liraglutide are approved by the US Food and Dr…
…ndomly allocated 1:1:1 to receive liraglutide, empagliflozin or linagliptin treatment. The primary outcome measure is the efficacy differen…
…ted the true neuroprotective effects of GLP-1 RAs compared with metformin. This underscores the potential superiority of GLP-1 RAs and hi…
…e age, duration of T2D, sex, BMI (<30, ≥30 and <35, ≥35 kg/m2), dulaglutide dose, and duration of dulaglutide treatment. The tirzepatide tr…